Moody Aldrich Partners LLC Tg Therapeutics, Inc. Transaction History

Moody Aldrich Partners LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 28, 2023	BUY	$15.48 - $35.0 $1.2 Million - $2.7 Million	77,278 New	77,278 $1.92 Million
Q4 2022 Jan 23, 2023	BUY	$5.01 - $11.83 $520,664 - $1.23 Million	103,925 New	103,925 $0
Q3 2021 Oct 29, 2021	SELL	$21.78 - $40.45 $1.62 Million - $3.02 Million	-74,599 Closed	0 $0
Q2 2021 Aug 04, 2021	SELL	$32.5 - $48.96 $29,542 - $44,504	-909 Reduced 1.2%	74,599 $2.89 Million
Q1 2021 May 10, 2021	BUY	$41.61 - $54.3 $51,929 - $67,766	1,248 Added 1.68%	75,508 $3.64 Million
Q4 2020 Feb 16, 2021	BUY	$25.27 - $54.9 $1.88 Million - $4.08 Million	74,260 New	74,260 $3.86 Million

338

87.6M

2.35M

1.7M

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $4.22B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

Get notified when there are updates to the investment portfolio of Moody Aldrich Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Moody Aldrich Partners LLC with notifications on news.